864 Intravenous (IV) vinorelbine (VRL) plus hormone therapy (HT) versus hormone therapy alone in hormone-refractory prostate cancer (HRPC). Final report of a randomised phase III study

Scientific publication - Journal Article uoadl:2951124 28 Read counter

Unit:
Faculty of Medicine
Title:
864 Intravenous (IV) vinorelbine (VRL) plus hormone therapy (HT) versus hormone therapy alone in hormone-refractory prostate cancer (HRPC). Final report of a randomised phase III study
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2003
Authors:
Abratt, RP
Brune, D
Dimopoulos, MA
Kliment, J
Breza, J
Selvaggi, P
Beuzeboc, P
Demkow, T
Oudard, S
Journal:
EJC supplements
Volume:
5
Number:
1
Pages:
S260
Main subject category:
Health Sciences
The digital material of the item is not available.